FDA Warning Letter — Boiron Inc.
The FDA took a Warning Letter action against Boiron Inc. on Sep 11, 2023 (Newtown Square, PA). The action was issued by CDER and concerns drugs products. This facility has 4 recent FDA inspections on record.
Action Details
- Facility
- Boiron Inc.
- Date
- Sep 11, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Center
- CDER
- Location
- Newtown Square, PA (United States)